133 related articles for article (PubMed ID: 15681751)
1. Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation.
Strober W; Fuss I; Boirivant M; Kitani A
Ann N Y Acad Sci; 2004 Dec; 1029():115-31. PubMed ID: 15681751
[TBL] [Abstract][Full Text] [Related]
2. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses.
Powrie F
Ann N Y Acad Sci; 2004 Dec; 1029():132-41. PubMed ID: 15681752
[TBL] [Abstract][Full Text] [Related]
3. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
5. Genetic selection for susceptibility to oral tolerance leads to a profound reduction of the acute inflammatory response.
da Silva Mde F; da Nóbrega A; Barja-Fidalgo TC; Brando-Lima AC; Cunha F; da Silva AC
Ann N Y Acad Sci; 2004 Dec; 1029():398-401. PubMed ID: 15681791
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of mucosal tolerance on experimental colitis in rats.
Shan-Shan Z; Yu-Lan L
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1145-52. PubMed ID: 19478680
[TBL] [Abstract][Full Text] [Related]
7. Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation.
Cardoso CR; Teixeira G; Provinciatto PR; Godoi DF; Ferreira BR; Milanezi CM; Ferraz DB; Rossi MA; Cunha FQ; Silva JS
Clin Exp Allergy; 2008 Feb; 38(2):338-49. PubMed ID: 18005184
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulatory T-cell networks in the mucosal immune system.
Suzuki I; Kiyono H; Kitamura K; Green DR; McGhee JR
Nature; 1986 Apr 3-9; 320(6061):451-4. PubMed ID: 3485772
[TBL] [Abstract][Full Text] [Related]
9. Interferon-λ mediates oral tolerance and inhibits antigen-specific, T-helper 2 cell-mediated inflammation in mouse intestine.
He SH; Chen X; Song CH; Liu ZQ; Zhou LF; Ma WJ; Zhao LD; Li TL; Tang SG; Xing Z; Yang PC
Gastroenterology; 2011 Jul; 141(1):249-58, 258.e1-2. PubMed ID: 21569774
[TBL] [Abstract][Full Text] [Related]
10. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
11. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice.
Kinoshita K; Hori M; Fujisawa M; Sato K; Ohama T; Momotani E; Ozaki H
Neurogastroenterol Motil; 2006 Jul; 18(7):578-88. PubMed ID: 16771773
[TBL] [Abstract][Full Text] [Related]
12. Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells.
Tsuji NM; Kosaka A
Trends Immunol; 2008 Nov; 29(11):532-40. PubMed ID: 18835746
[TBL] [Abstract][Full Text] [Related]
13. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
14. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.
Boirivant M; Amendola A; Butera A; Sanchez M; Xu L; Marinaro M; Kitani A; Di Giacinto C; Strober W; Fuss IJ
Gastroenterology; 2008 Nov; 135(5):1612-1623.e5. PubMed ID: 18765239
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G
Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.
Srinivasan M; Summerlin DJ
Clin Immunol; 2009 Dec; 133(3):411-21. PubMed ID: 19811954
[TBL] [Abstract][Full Text] [Related]
17. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
18. Oral tolerance therapy in an experimental model of colitis.
Lee H; Barrett TA
Am J Gastroenterol; 2000 Apr; 95(4):861. PubMed ID: 10763923
[No Abstract] [Full Text] [Related]
19. Type 1 and 2 T helper cell-mediated colitis.
Dohi T; Fujihashi K
Curr Opin Gastroenterol; 2006 Nov; 22(6):651-7. PubMed ID: 17053444
[TBL] [Abstract][Full Text] [Related]
20. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease.
Kelsall BL; Leon F
Immunol Rev; 2005 Aug; 206():132-48. PubMed ID: 16048546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
